Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Return on Equity (2021 - 2026)

GeneDx Holdings has reported Return on Equity over the past 6 years, most recently at 0.0% for Q1 2026.

  • Quarterly Return on Equity changed 0.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Equity was 0.0% for Q1 2026 at GeneDx Holdings, down from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q3 2025 and troughed at 0.02% in Q1 2023.
  • The 5-year median for Return on Equity is 0.0% (2024), against an average of 0.01%.
  • Year-over-year, Return on Equity decreased -3bps in 2022 and then rose 1bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.01% in 2022, then soared by 46bps to 0.01% in 2023, then surged by 68bps to 0.0% in 2024, then surged by 70bps to 0.0% in 2025, then plummeted by -296bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for WGS's Return on Equity are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).